Amphotericin B Plasma Monitoring for One Burn Child Using High-Performance Liquid Chromatography

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSANCHES-GIRAUD, Cristina
dc.contributor.authorGOMEZ, David S.
dc.contributor.authorCAMPOS, Edvaldo V.
dc.contributor.authorAZEVEDO, Rodrigo P. de
dc.contributor.authorDESPINOY, Alessandra
dc.contributor.authorPEREZ, Grazziela S.
dc.contributor.authorFERREIRA, Marcus C.
dc.contributor.authorSANTOS, Silvia R. C. J.
dc.date.accessioned2017-11-27T16:20:35Z
dc.date.available2017-11-27T16:20:35Z
dc.date.issued2011
dc.description.abstractA bioanalytical micromethod was described for the quantification of amphotericin B in plasma by HPLC. The method showed high absolute recovery, good linearity (0.1-10.0 mu g/mL, r(2) = 0.999), sensitivity (limits of quantification: 0.1 mu g/mL), and acceptable stability. Inter/intraday precisions were 6.8 %/23 % and mean accuracy was 94.3 %. The method was applied to plasma monitoring of one burn child, 3 years old, 25 kg, thermal injury (18 % total burn surface area - TBSA). Amphotericin B (1 mg/kg) was prescribed from 24(tg) to 35(tg) day of the accident and plasma monitoring and pharmacokinetics was performed by serial blood collections on 274 and 354 days post burn. Plasma concentrations obtained were respectively 0.7 mu g/mL and 1.2 mu g/mL. Pharmacokinetics at both periods (27(tg) vs 35(tg) day) also was compared: 13.8 vs 14.3 h (t(1/2 beta)); 0.5 vs 03 mL/min.kg (CL(T)) and 0.65 vs 038 L/kg (Vd(ss)). In conclusion, drug plasma monitoring by HPLC was quite useful to guarantee low risk and drug efficacy in a paediatric burn patient.
dc.description.indexWoS
dc.description.sponsorshipCAPES
dc.description.sponsorshipCNPq
dc.description.sponsorshipFAPESP
dc.identifier.citationLATIN AMERICAN JOURNAL OF PHARMACY, v.30, n.8, p.1468-1474, 2011
dc.identifier.issn0326-2383
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/22455
dc.language.isoeng
dc.publisherCOLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
dc.relation.ispartofLatin American Journal of Pharmacy
dc.rightsrestrictedAccess
dc.rights.holderCopyright COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
dc.subjectAmphotericin B
dc.subjectBurn child
dc.subjectDrug plasma monitoring
dc.subjectHPLC-UV
dc.subjectPharmacokinetics
dc.subject.otherinternal standard
dc.subject.othermalignant diseases
dc.subject.otherhuman-serum
dc.subject.otherpharmacokinetics
dc.subject.otherassay
dc.subject.otherpharmacodynamics
dc.subject.otherextraction
dc.subject.wosPharmacology & Pharmacy
dc.titleAmphotericin B Plasma Monitoring for One Burn Child Using High-Performance Liquid Chromatography
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalSANCHES-GIRAUD, Cristina:Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil
hcfmusp.author.externalCAMPOS, Edvaldo V.:Univ Sao Paulo, Hosp Clin, Fac Med, BR-05508 Sao Paulo, Brazil
hcfmusp.author.externalPEREZ, Grazziela S.:Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil
hcfmusp.author.externalSANTOS, Silvia R. C. J.:Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcDAVID DE SOUZA GOMEZ
hcfmusp.contributor.author-fmusphcRODRIGO PALACIO DE AZEVEDO
hcfmusp.contributor.author-fmusphcALESSANDRA DESPINOY
hcfmusp.contributor.author-fmusphcMARCUS CASTRO FERREIRA
hcfmusp.description.beginpage1468
hcfmusp.description.endpage1474
hcfmusp.description.issue8
hcfmusp.description.volume30
hcfmusp.origemWOS
hcfmusp.origem.scopus2-s2.0-84856266693
hcfmusp.origem.wosWOS:000298869100002
hcfmusp.publisher.cityLA PLATA
hcfmusp.publisher.countryARGENTINA
hcfmusp.relation.referenceItalia JL, 2009, ANAL CHIM ACTA, V634, P110, DOI 10.1016/j.aca.2008.12.006
hcfmusp.relation.referenceWatt K, 2011, EARLY HUM DEV, V87, pS61, DOI 10.1016/j.earlhumdev.2011.01.014
hcfmusp.relation.referenceEspada R, 2008, BIOMED CHROMATOGR, V22, P402, DOI 10.1002/bmc.947
hcfmusp.relation.referenceGALLIS HA, 1990, REV INFECT DIS, V12, P308
hcfmusp.relation.referenceAndes D, 2006, INFECT DIS CLIN N AM, V20, P679, DOI 10.1016/j.idc.2006.06.007
hcfmusp.relation.referenceBlanchet B, 2008, CLIN PHARMACOKINET, V47, P635, DOI 10.2165/00003088-200847100-00002
hcfmusp.relation.referenceBENSON JM, 1989, ANTIMICROB AGENTS CH, V33, P1989
hcfmusp.relation.referenceNath CE, 2001, BRIT J CLIN PHARMACO, V52, P671, DOI 10.1046/j.0306-5251.2001.01496.x
hcfmusp.relation.referenceEldem T, 2001, J PHARMACEUT BIOMED, V25, P53, DOI 10.1016/S0731-7085(00)00499-4
hcfmusp.relation.referenceAntachopoulos C, 2006, J CLIN MICROBIOL, V44, P553, DOI 10.1128/JCM.44.2.553-560.2006
hcfmusp.relation.referenceBACH PR, 1984, ANTIMICROB AGENTS CH, V26, P314
hcfmusp.relation.referenceCatalan Mercedes, 2006, Revista Iberoamericana de Micologia, V23, P39
hcfmusp.relation.referenceCleary JD, 2007, J ANTIMICROB CHEMOTH, V60, P1331, DOI 10.1093/jac/dkm322
hcfmusp.relation.referenceEchevarria I, 1998, J CHROMATOGR A, V819, P171, DOI 10.1016/S0021-9673(98)00425-7
hcfmusp.relation.referenceEgger P, 2001, J CHROMATOGR B, V760, P307, DOI 10.1016/S0378-4347(01)00292-4
hcfmusp.relation.referenceFDA Home page, 2008, GUID IND BIOAN METH
hcfmusp.relation.referenceGRANICH GG, 1986, ANTIMICROB AGENTS CH, V29, P584
hcfmusp.relation.referenceGuszecki W.I, 2002, FEBS LETT, V524, P92
hcfmusp.relation.referenceHOSOTSUBO H, 1988, ANTIMICROB AGENTS CH, V32, P1103
hcfmusp.relation.referenceHOSOTSUBO H, 1989, J PHARMACEUT BIOMED, V7, P975, DOI 10.1016/0731-7085(89)80022-6
hcfmusp.relation.referenceLambros MP, 1996, J CHROMATOGR B, V685, P135
hcfmusp.relation.referenceLopezGalera R, 1995, J CHROMATOGR B, V674, P298, DOI 10.1016/0378-4347(95)00322-3
hcfmusp.relation.referenceNath CE, 2007, CHEMOTHERAPY, V53, P142, DOI 10.1159/000100013
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationcd8ea120-e2b5-45c4-b22b-417ea783e927
relation.isAuthorOfPublication2d85d914-b60c-4193-842c-944b8929b714
relation.isAuthorOfPublication9f588bb6-67c2-44dd-8821-d7267b0b0de3
relation.isAuthorOfPublication89a2a507-401a-4243-8a20-12e3bfa47bff
relation.isAuthorOfPublication.latestForDiscoverycd8ea120-e2b5-45c4-b22b-417ea783e927
Arquivos